Furthermore, endogenous ligands for AhR may block the NF-κB signaling pathway and lessen local inflammation in bronchitis, periodontitis and colitis (Yu et al. 2018; Takenaka et al. 2019; Li et al. 2019). Here, NFKB1 is linked to bronchial disorder.